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Abstract
Objective:  Priapism is a fairly  uncommon presentation to the emergency paediatrics
department, but when it does present, it represents a real urologic emergency. Prompt
treatment  will  decrease  the  risk  of  permanent  consequences  including  impotency.
Treatment should be based on aetiology, followed by an organized approach [1]. This
report discusses a case of recurrent attacks of idiopathic priapism in a 13-year-old boy
comparing the treatment with other experiences.
Patient and methods: A 13-year-old boy was diagnosed at our hospital with idiopathic
priapism  which  always  happened  at  waking  up  time  and  which  responded  to  oral
diazepam and local ice pad therapy. Diagnosis was confirmed after exclusion of all other
causes.  This  type  of  management  was  compared  with  retrospectively  reviewed  and
reported in the PubMed web site.
Results: Successful treatment of recurrent idiopathic priapism with oral administration of
diazepam and local ice pad.
Conclusion: As the problem was solved completely after the fifth attack of priapism, the
utilisation of  oral  diazepam and local  ice pad therapy may be considered as a  less
invasive method for the management of recurrent idiopathic priapism in children.
Introduction
Priapism is a persistent penile erection that continues beyond 4 hours of duration, is
unrelated to sexual stimulation and with no ejaculation [2]. Two variants of priapism have
been well described: the ischaemic "anoxic" form also known as low-flow priapism and
the  non-ischemic  form  or  high-flow  priapism.  Priapism  is  considered  a  urological
emergency.  Immediate evaluation and treatment are needed to avoid severe erectile
dysfunction  related  to  intracavernous  fibrosis.  A  number  of  different  aetiologies  of
priapism have  been  described  including  perineal  trauma,  carcinoma of  the  penis  or
neighbouring  organs,  sickle  cell  disease,  other  rare  types  of  anaemia,  leukaemia,
thromboembolic  disease,  neurological  disorders,  prolonged  sexual  stimulation,
intracavernous injection of pharmacologic agents, and idiopathic causes [3-4].
Guidelines  to  treat  priapism  in  paediatric  and  adolescence  age  have  not  yet  been
established because of rarity of published cases. In this article we shall review some of
them.
When Hinman first described a neural type of priapism, he had observed that priapism
occurs  in  patients  with  overt  neurological  disorders  [5].  Munro  et  al  reported  an
association between paraplegia and priapism.  Their  report  consisted of  221 men,  of
whom 10% were assessed to have priapism, including 14% with cervical,  6.5% with
thoracic, 5% with lumbosacral and 3% with cauda equina level injuries [6].
There were reported cases of intermittent priapism which appeared spontaneously with
exercise and then resolved with rest.  This has been seen to occur in relation to the
cauda  equina  compression  syndrome,  a  neurological  syndrome which  also  includes
intermittent low back pain, lower extremity dysesthesia and voiding difficulties [7, 8]. All
symptoms of this syndrome are worsened by extension of the lumbar spine and relieved
by flexion or sitting. Known diagnostic entities relating to the syndrome are lumbar disc
herniation [7], severe lumbar spinal cord stenosis [8], and cauda equina compression.
Hinman reported that idiopathic priapism was usually associated with sexual activity and
a preceding event [10]  .  Idiopathic priapism is defined as a painful  prolonged penile
erection  without  a  clear  aetiology.  Many  investigators  have  reported  that  idiopathic
priapism occupy 50% of all documented cases [9]. Some psychiatric centres reported
cases of priapism in response to erogenous stimuli and genital manipulation[10]. Even
sleep related involuntary erections can precede priapism episodes [5, 11, 12, 13].
Hinman also recognized that  some recurrent forms of  priapism have limited duration
compared with true priapism, which he termed "acute transitory attacks or Stuttering
Priapism"  [5].  He  also  identified  multiple,  self-limiting,  frequently  recurrent  priapism
episodes in patients with sickle cell disease [14]. The attacks were beginning soon after
puberty  and  then  evolving  variably  during  weeks,  months  or  even  years  with  some
culminating in a major episode lasting 3 to 5 days and some up to 4 weeks [14, 15].
More than 40% of the men in this category experienced attacks during the waking hours
[11].  Stuttering  episodes  have  rarely  been  associated  with  complete  erectile
dysfunction[11, 14, 15].
Refractory priapism was described by some authors as a recurrent erectile state that
immediately  follows  aspiration  or  incision  of  the  corpora  cavernosa  for  apparently
ischemic priapism [10, 12,  16,  17].  This form of  priapism resulted from rapid arterial
blood refilling the penis after treatment rather than further venous congestion [10]. Use of
blood gas analysis through penile aspirates supported this impression [12]. Additional
investigators more recently used penile colour duplex ultrasonography to document the
conversion of veno-occlusive priapism after initial treatment to a high flow non-ischemic
form [16, 17].
Since arteriocavernous fistulas were not radiographically apparent in these cases, Hakim
et al reported a 66% rate of recurrent non-ischemic priapism following initial embolization
of an arteriocavernous tissue fistula for post-traumatic arterial priapism despite evidence
of successful proximal arterial occlusion on selective pelvic arteriography [18]. Persistent
elevated distal  arterial  blood flow was characterized by having a turbulent quality on
colour duplex ultrasonography. The return to complete flaccidity was delayed even when
detumescence started after selective embolization. Foda et al settled on the diagnosis of
high flow priapism in  a  child  with  Fabry’s  disease [19],  in  which priapism had been
reported and attributed previously to lipid infiltration of the cavernous tissue.
Priapism has been observed to occur also after drug administration. Rubin first identified
this relationship and determined that it was cause and effect-based on his evaluation of
patients  in  whom  priapism  developed  after  receiving  the  antihypertensive  agents
hydralazine and guanethidine [20].  Rubin reported the onset  of  recurrent  self-limiting
erections extending up to several hours in duration after consumption of these drugs.
Similarly rare priapism episodes have been reported with the use of alpha-adrenergic
[21]. Priapism has also been associated with psychotropic and antidepressant agents
such  as  trazodone  trimipramine  (tricyclic  antidepressant)  and  clozapine  [23]  which
implicate peripheral and central neuronal mechanisms for the erectile response [22, 23].
Intraurethral  administration  of  alprostadil  [24]  and  oral  sildenafil  [25]  for  erectile
dysfunction  have  also  been  implicated  in  priapism in  association  with  the  corporeal
smooth  muscle  relaxatory  effects  of  the  vasoactive  drugs  used  in  these  therapies.
General or regional (spinal or epidural) anaesthesia has been associated with priapism
[26].  Highly  refractory  priapism resulting  from heavy  alcohol  intake  [5,  9],  topical  or
intranasal  cocaine  [27],  administration  of  immunosuppressant  agent  fk506  [28],  and
androgen therapy have also been reported. Boaz Meijer reported a case of neonatal
priapism on the first day after birth which disappeared after 4 days of observation [40].
Case presentation
A 13-year-old  previously  healthy  boy  presented  to  the  paediatrics  emergency  room
suffering from prolonged (three hours) painful penile erection which occurred at the time
of  waking  up  in  the  morning.  The  patient  had  not  been  involved  in  intercourse,
masturbation, proximal or remote trauma, drug or alcohol assumption and recent sport
activity. There was no family history of sickles cell  anaemia or leukaemia. One week
before, he had presented with a similar attack which had been treated in another centre
with oral diazepam and the application of a local ice pad with little response and then the
penis had detumesced after a corpus cavernosum direct injection of alpha-adrenergic
agonist "Etilefrine". He had been given oral diazepam at home just before coming to our
hospital. In our paediatrics emergency department, clinical examination revealed erect
corpora cavernosa without swelling of corpus spongiosum or ecchymosis, and moderate
phimosis.  Vital  signs  and  other  clinical  parameters  were  in  the  normal  range.  The
erection never detumesced and became progressively painful.  Cavernosal  blood gas
analysis  values  were  pH  7.39,  pCO2  37.1  mmHg,  pO2  53,  8  mmHg,  HCO3-  21.9
mmol/L. Complete blood count and the coagulation profile were all in a normal range.
Diazepam 2 mg orally was administrated to him together with the application of a local
ice  compression  but  with  moderate  benefit.  Toxicology  tests  were  positive  only  for
benzodiazepine. Andrological tests were requested, and echocolordoppler sonography
was performed at the base of the penis, which revealed asymmetric increased blood flow
in the cavernous artery (Right 26 cm/sec, Left 40 cm/sec) with thickened area in the left
proximal medium of corpus cavernosum tissue.
During  hospitalization  the  patient  was  administered  oxygen  therapy  2L/min  for  30
minutes  before  going  to  sleep.  No  secondary  cause  of  priapism  was  documented.
Haemoglobin  electrophoresis,  reticulocytes,  alpha-fetoprotein,  thyroid  function  test,
Human  chorionic  gonadotropin  (HCG),  follicle-stimulating  hormone  (FSH),  luteinizing
hormone  (LH),  Testosterone,  Dehydroepiandrosterone  sulfate  (DHEAS),  pharyngeal
smear,  urine  culture,  electrocardiogram,  abdominal  ultrasound,  haematological  and
andrological clinical tests resulted in the normal range. The patient was then discharged
in good health.
One week after his discharge, the child at wake up time in the morning presented with an
analogous episode which responded after 2 hours to diazepam 2 mg orally and with
local ice compression.
One month later there were three other analogous episodes a distance of 15-20 days
apart  and  all  were  responsive  after  30  minutes  to  1  hour  to  diazepam 2  mg orally
associated with local ice compression.
The patient delivered to our emergency department during these episodes and was then
discharged  without  any  further  treatment.  After  our  patient  had  no  recurrent  similar
attacks of priapism for eighteen months, he underwent to circumcision intervention due
to moderate phimosis.
Priapism was defined idiopathic, by excluding trauma, haematological,  pharmacologic
and neurological causes.
Discussion
Recurrent  idiopathic  priapism is  a rare condition and its  treatment  has not  yet  been
standardised  [29].  It  is  a  difficult  problem  to  treat  and  a  true  emergency  for  the
physicians,  and often even invasive therapeutic  interventions fail.  Idiopathic  priapism
commonly induces thoughts of an enigmatic disorder, in which penile erection persists
more than four hours in the absence of sexual excitation.
This concept derive from the understanding of the physiological equilibrium of the penis,
involving the interplay of different neuro-effectors, hormones, vaso-active substances,
signal transduction systems and corporeal tissue, cellular and molecular factors which
govern the tone of corporeal smooth muscle and determine its functional responsiveness
to erectile stimuli [30-31].
The implication is that dysregulatory mechanisms provide a basis for priapism to occur
as a manifestation of an unbalanced erectile tissue response.
The  major  complication  of  the  ischaemic  type  of  priapism  is  the  development  of
irreversible penile fibrosis resulting in definitive erectile dysfunction.
The risk factors are: duration of the priapism (with increasing risk beyond 48 hours) and
incomplete detumescence despite therapy [32].
Few  cases  have  been  published  and  the  unavailability  of  literature  has  made  it
impossible to develop evidence-based guidelines [2].
For many years,  numerous methods have been employed for treatment of  idiopathic
priapism such as oral administration of Digoxin (positive inotropic agent), but it is difficult
to  maintain  at  its  optimal  serum  level.  Also,  oral  administration  of  Baclofen
(y-aminobutyric acid receptor agonist) and Gabapentin taken orally have proven to be a
new effective alternative without serious effect on the normal erectile function[35-36].
Therapy with Ketoconazole and Prednisone is helpful to prevent recurrence of attacks of
priapism [37].
+Dahm  et  al  established  that  oral  administration  of  antiandrogens  resulted  in  a
significant  improvement  in  three  patients  with  refractory  priapism  [34].  Steven  et  al
confirmed that inhalation treatment by amyl nitrite was successful treatment for recurrent
idiopathic priapism [37].
One of the traditional treatments of priapism is intracavernous injection of adrenaline
which is used for young patients who have no cardiovascular disease [13-33].
Another alternative therapy is intracavernous injection of  Methylene blue (a powerful
inhibitor of nitric oxide), which is effective and safe in cardiac patients [38].
In our case the patient was treated for the first attack of priapism with intracavernosal
Etilefrine injection.
In the 4 subsequent attacks, the administration of oral diazepam and the application of
local ice were sufficient to obtain a complete detumescence after 1-2 hours. It may be
that ice stimulates vasoconstriction which helps to drain out the blood from the corpus
cavernosum and that Diazepam works by relaxing tension in the patient.
Conclusion
This case report shows that the administration of oral diazepam plus applications of local
ice were sufficient to achieve a complete resolution of priapism after 1-2 hours. This
treatment may be considered as one of the options for the management of recurrent
episodes of idiopathic priapism.
However,  our  patient  underwent  intracavernosal  injection  with  Etilefrine  for  the  first
attack, but the successive attacks were treated with oral diazepam and direct perineal
application of ice.
Because this treatment was not invasive and our patient remained eighteen months free
from priapism, we can consider oral diazepam and direct perineal application of ice as
the first line for treatment of priapism.
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